Abbott Laboratories (ABT) Treasury Shares (2009 - 2026)

Abbott Laboratories has disclosed Treasury Shares across 18 years of filings, most recently posting $16.9 billion for Q1 2026.

• Treasury Shares for Q1 2026 came in at $16.9 billion, up 1.94% year-over-year; the trailing twelve-month figure through Mar 2026 was $16.9 billion (up 1.94% YoY), and the FY2025 annual result was $17.2 billion, up 1.98% from the prior year.
• Treasury Shares came in at $16.9 billion for Q1 2026 at Abbott Laboratories, down from $17.2 billion in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $260.2 million in Q4 2025 to a low of $234.5 million in Q2 2022.
• The 5-year median for Treasury Shares is $251.8 million (2023), against an average of $251.1 million.
• Across the five-year window, Treasury Shares jumped 39.42% in 2022 and increased 0.24% in 2024, its largest moves.
• Abbott Laboratories' Treasury Shares stood at $15.2 billion in 2022, then advanced by 4.94% to $16.0 billion in 2023, then increased by 5.4% to $16.8 billion in 2024, then advanced by 1.98% to $17.2 billion in 2025, then declined by 1.41% to $16.9 billion in 2026.
• The last three Treasury Shares figures came in at $16.9 billion (Q1 2026), $17.2 billion (Q4 2025), and $16.9 billion (Q3 2025), per Business Quant data.